Woodcock: US at an 'Inflection Point' for Targeted Therapies | GenomeWeb

In a plenary session at the Partnering for Cures conference being held in New York City this week, the Food and Drug Administration's Margaret Hamburg and Janet Woodcock announced the agency's latest draft guidance for industry, which aims, among other things, to enhance collaboration among pharmaceutical firms throughout the drug-development process.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.